News

CeMM-Research work published in Nature

CeMM-Research work published in Nature: Viruses give insight into the vulnerability of the defense mechanisms of human...

Nabriva Therapeutics Announces Management Changes

Vienna, Austria- 18 July 2012 - Nabriva Therapeutics, a biotechnology company focused on developing a new class of...

MedUni Vienna announces collaboration with the Johns Hopkins University Carey Business School

(Vienna/Baltimore, 17-07-2012) The Medical University of Vienna, one of Europe’s medical training and research...

MedUni Vienna: A weak heart produces a poor appetite

(Vienna 11th July 2012) Heart-brain-stomach link of major importance for diabetes and heart failure discovered: as a...

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients.

Successful delivery of PICSO® catheter and administration of PICSO® treatment designed to improve myocardial perfusion...

TU Wien: Zell-Stress erhöht die Produktivität

Sorry, this entry is only available in German!

APEPTICO Initiates Phase II Trial with AP301 in Patients with Pulmonary Oedema

Vienna, Austria, June 29, 2012 - APEPTICO, a privately-held biotechnology company developing peptide drugs based on its...

Biomay to present at the Rodman & Renshaw 14th Annual Global Healthcare Conference

Biomay AG announced today that the company has been selected to present at the prestigious 14th Annual Global Healthcre...

Biomay: Innovative Grass Pollen Allergy Vaccine Shows Efficacy in Phase IIA Trial

A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The...

Boehringer Ingelheim BioXcellence: Distinctive brand for the biopharmaceutical contract manufacturing business

Vienna/Austria, 27 June 2012 –With Boehringer Ingelheim BioXcellence the pharmaceutical company Boehringer Ingelheim set...

aws: BOB Phase 2

AWS, Vienna, 22 June 2012, Phase 2 for the international life science business plan competition Best of Biotech 2012...

Campus Vienna Biocenter: New play by Carl Djerassi at the Campus Vienna Biocenter Vienna

Carl Djerassi, inventor of the pill and the author of numerous novels and plays, has chosen the Campus Vienna Biocenter...